Profile for Menlo Therapeutics Inc. (MNLO)

$ 1.59   -0.03 (-1.85%) Volume: 2.01m 4:00 PM EDT 12-Aug-2020
After Hours:  $ 1.61   0.02 (+1.26%) Volume: 5.29k 7:57 PM EDT 12-Aug-2020
Business Description:
Menlo Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.
Address: 200 Cardinal Way, 2nd Floor, Redwood City, CA, USA, 94063
Telephone: +1 650 486-1416 Website:
Facsimile: N/A Email: [email protected]
CEO: David Domzalski
Employees: 181 Market Cap: 266.63m
Issue Type: CS
Auditor: Mayer Hoffman McCann P.C.
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1566044
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)